Region: European Union

Spain could join the UPC during EU presidency, says top Barcelona patent judge

In an exclusive IAM interview, Judge Florencio Molina López talks about his court’s approach to the Mobile World Congress as well as the country’s potential entry into the Unified Patent Court

18 July 2022

The EU SPC manufacturing waiver transitional period comes to an end

Life sciences companies in Europe are now operating under a regime in which many more patent extension rights are affected by exemptions

05 July 2022

Ireland commits to UPC referendum – here’s everything you need to know

Local IP professionals are hoping for a vote in early 2023 but may have to wait longer, while outcome is also uncertain

01 July 2022

UK plans to diverge from EU on AI-related IP exemption

Moves announced after consultation will affect copyright and database rights, but leave status quo in place for inventorship

29 June 2022

Dutch courts will still award cross-border injunctions to patent holders despite Boston Scientific setback

The refusal of a judge in Amsterdam to grant the US company relief covering Ireland, France and Germany does not indicate major change to the regime

28 June 2022

French appeal court SPC decision is good news for biologics innovators

Following a string of adverse rulings against inventors, Paris Court of Appeal overturns patent office rejection of supplementary protection certificate on Article 3(a) grounds

20 June 2022

UPC opt-out strategies are now a matter of urgency

Decisions on what to do with existing European patent bundles could be required within the next month

09 June 2022

UCal further strengthens CRISPR position in Europe, but Cas9 licensing situation remains tricky

EPO Opposition Division upholds another key Doudna patent, but several gene-editing appeals are still in play

26 May 2022

How to approach patenting innovation around digital biomarkers

It is essential for practitioners to be aware of the main areas of focus for patent protection for digital biomarkers and their correlations to specific medical conditions, to ensure that any resulting protection helps to deliver enhanced treatment and diagnosis of a range of medical conditions.

25 May 2022

SEP stakeholders weigh in as EU mulls changes to FRAND framework

Reaction to a Commission call for evidence was more muted than the recent consultation exercise in the US, but raised some important points specific to Europe

24 May 2022

Unlock unlimited access to all IAM content